By the same authors

From the same journal

From the same journal

When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development? A Systematic Review of NICE Guidance

Research output: Contribution to journalArticle

Author(s)

Department/unit(s)

Publication details

JournalPharmacoeconomics
DatePublished - Feb 2013
Issue number2
Volume31
Number of pages13
Pages (from-to)137-149
Original languageEnglish

Abstract

There is growing interest internationally in linking reimbursement decisions with recommendations for further research. In the UK, the National Institute for Health and Clinical Excellence (NICE) can issue guidance to approve the routine use of a health intervention, reject routine use or recommend use within a research programme. These latter recommendations have restricted use to 'only in research' (OIR) or have recommended further research alongside routine use ('approval with research' or AWR). However, it is not currently clear when such recommendations are likely to be made.

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations